Georgia World Congress Center
Room B403
Atlanta, GA

PROGRAM DESCRIPTION

The prevalence of severe aortic stenosis is a significant problem in the aging population, and carries a poor prognosis. Although surgery is a proven effective treatment, only about one-third of patients are referred for such therapy, as those with ventricular dysfunction and comorbidities are too high-risk and, therefore, ineligible for surgery. Recent innovations in minimally invasive approaches for aortic valve replacement have the potential to revolutionize the treatment of aortic stenosis in patients who are not candidates for aortic valve replacement surgery. Trans-catheter aortic valve replacement (TCAVR) is a growing hybrid specialty that requires improved skill sets and tightly collaborative multidisciplinary treatment teams, which will ultimately lead to expanded use of TCAVR in clinical practice. Interventional cardiologists and cardiac surgeons need to keep abreast of the latest clinical trial results, and apply these insights to clinical practice as new devices and technologies gain regulatory approval.

This CME activity will help close these educational gaps among cardiologists who treat patients in need of aortic valve replacement. Participants will be brought up to date with the latest clinical trial results on TCAVR devices and delivery techniques in patients who are ineligible for surgery. The program will also provide valuable insights into the development of "state-of-the-science" specialty centers, as smaller, more refined delivery devices are expected to expand the use of TCAVR in suitable patient populations.

Faculty

	Ganesh Manoharan, MBBCh, MD, FRCP(I), FRCP(Edin)–Chair University of Ulster Belfast, United Kingdom
	Marc Ruel, MD, MPH, FRCSC University of Ottawa Heart Institute Ottawa, Ontario, Canada
	Raoul Bonan, MD University of Montreal Montreal Heart Institute Montreal, Quebec, Canada

AGENDA

8:30–9:00 AM: Registration and Breakfast

9:00–10:15 AM: CME Program

10:15–10:30 AM: Question and Answer Segment

TARGET AUDIENCE

This program was developed for cardiologists and other cardiovascular health care professionals who treat patients in need of aortic valve replacement.

EDUCATIONAL OBJECTIVES

This activity was designed to address the following IOM competencies: provide patient-centered care, and employ evidence-based practice.

Upon completion of this program, attendees will be able to:

• Describe the risk assessment tools used to identify high-risk patients who would not qualify for standard aortic valve replacement surgery, and the overall percentage of such patients that would be deemed ineligible for this procedure
• Discuss the two major minimally invasive transcatheter aortic valve replacement procedures, and the key differentiating features of each
• Explain practical aspects of creating a TCAVR facility, including collaborative specialty teams, requirements of a hybrid medical facility, and continuous skills improvement

ACCREDITATION

The Potomac Center for Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

DESIGNATION STATEMENT

The Potomac Center for Medical Education designates this educational activity for a maximum of 1.5 AMA PRA Category 1 credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

DISCLOSURE INFORMATION

Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Commercial Support, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.

All persons in a position to control the content of a continuing medical education program sponsored by the Potomac Center for Medical Education are required to disclose any relevant financial relationships with any commercial interest to PCME, as well as to learners. All conflicts are identified and resolved by PCME in accordance with the Standards for Commercial Support in advance of delivery of the activity to learners. Disclosures will be made known to the participants prior to the activity.

The content of this activity was vetted by an external medical reviewer to assure objectivity and that the activity is free of commercial bias.

FDA Disclosure

The contents of some CME/CE activities may contain discussions of non-approved or off-label uses of some agents mentioned. Please consult the prescribing information for full disclosure of approved uses.

SPECIAL SERVICES

Event staff will be glad to assist you with any special needs (physical, dietary, etc.).

 

Sponsored by:

This program is supported through an educational grant from

By clicking this button you are agreeing that you have read and understood the CME Statements above.